Preliminary validation of a health-related quality of life symptom index for persons treated or actively monitored for anal HSIL (AMC –A02, -A03)

Preliminary validation of a health-related quality of life symptom index for persons treated or actively monitored for anal HSIL (AMC –A02, -A03)

Background: Precancerous anal high-grade squamous intraepithelial lesions (HSIL) and its associated treatments have the potential to reduce health-related quality of life (HRQoL) in impacted individuals. The ANCHOR (ANal Cancer HSIL Outcomes Research) trial aims to determine whether treating anal HS...

Full description

Bibliographic Details
Main Authors: Thomas M. Atkinson, PhD, Joel Palefsky, MD, J. Michael Berry, MD, Stephen Goldstone, MD, Andrew Webb, Rebecca Levine, MD, Timothy J. Wilkin, MD, MPH, Gary Bucher, MD, David Cella, PhD, Jeannette Lee, PhD, Jeff Taylor, Yuelin Li, PhD, Jack Burkhalter, PhD
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Papillomavirus Research
Online Access:http://www.sciencedirect.com/science/article/pii/S2405852118300508

Internet

http://www.sciencedirect.com/science/article/pii/S2405852118300508

Similar Items